| Literature DB >> 28260879 |
Steven Sadhra1, Om P Kurmi2, Sandeep S Sadhra1, Kin Bong Hubert Lam2, Jon G Ayres1.
Abstract
BACKGROUND: The association between occupational exposure and COPD reported previously has mostly been derived from studies relying on self-reported exposure to vapors, gases, dust, or fumes (VGDF), which could be subjective and prone to biases. The aim of this study was to assess the strength of association between exposure and COPD from studies that derived exposure by job exposure matrices (JEMs).Entities:
Keywords: COPD; airborne substances; job exposure matrices; occupation
Mesh:
Substances:
Year: 2017 PMID: 28260879 PMCID: PMC5327910 DOI: 10.2147/COPD.S125980
Source DB: PubMed Journal: Int J Chron Obstruct Pulmon Dis ISSN: 1176-9106
Figure 1Flowchart of the number of articles in different stages of the selection strategy.
Abbreviation: JEMs, job exposure matrices.
Results of quality assessment of the 29 studies included in the meta-analysis
| References | Types of bias assessed and question numbers
| ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selection bias, confounding (2 and 3 only)
| Performance bias
| Detection bias, confounding (6 only)
| Attrition bias, detection bias (8 only)
| Selective outcome reporting
| Confounding
| Overall assessment
| |||||||
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | |
| Paulin et al | + | + | + | + | ? | + | • | • | + | • | + | − | + |
| Toren and Jarvholm | + | + | + | + | ? | + | + | + | + | • | + | − | + |
| Dijkstra et al | + | + | + | ? | ? | + | • | + | + | • | + | + | + |
| Doney et al | + | + | + | ? | ? | + | • | ? | + | • | + | + | + |
| Rodriguez et al | + | + | + | + | ? | + | • | • | + | • | + | − | + |
| Hansell et al | + | + | + | ? | ? | + | • | − | + | • | + | − | + |
| Pallasaho et al | + | + | + | + | ? | + | + | − | + | • | + | − | + |
| Darby et al | + | + | + | ? | ? | + | • | − | + | • | + | + | ? |
| Mehta et al | + | + | ? | + | ? | + | + | + | + | • | + | − | + |
| Nordby et al | + | + | ? | + | ? | + | • | • | + | • | + | − | + |
| Govender et al | + | + | ? | + | ? | + | • | • | + | • | + | − | + |
| Soyseth et al | + | + | ? | + | ? | + | + | ? | + | • | + | + | + |
| Skorge et al | + | + | + | + | ? | + | + | − | + | • | + | − | + |
| Jacobsen et al | + | − | ? | + | ? | + | + | − | + | • | + | − | + |
| Blanc et al | + | ? | ? | + | ? | + | • | + | + | • | + | − | + |
| Blanc et al | + | ? | + | + | ? | + | • | − | + | • | + | − | + |
| Rodriguez et al | + | + | + | + | ? | + | • | • | + | • | + | − | + |
| Jacobsen et al | + | − | ? | + | ? | + | + | + | + | • | + | − | + |
| Weinmann et al | + | − | + | + | ? | + | • | + | + | • | + | − | + |
| Matheson et al | + | + | ? | + | ? | + | • | − | + | • | + | − | + |
| Sunyer et al | + | + | + | + | ? | + | + | + | + | • | + | − | + |
| de Meer et al | + | + | + | ? | ? | + | • | + | + | • | + | − | + |
| Trupin et al | + | + | ? | + | ? | + | • | − | + | • | + | − | + |
| Mastrangelo et al | + | + | ? | + | ? | + | • | • | + | • | + | − | + |
| Zock et al | + | + | + | ? | ? | + | • | + | + | • | + | − | + |
| Albin et al | + | + | + | ? | ? | + | • | − | + | • | + | − | + |
| Sunyer et al | + | + | + | ? | ? | + | • | − | + | • | + | − | + |
| Hsairi et al | + | + | + | + | ? | − | • | − | + | • | + | − | + |
| Bakke et al | + | + | + | + | ? | + | • | + | + | • | + | − | ? |
Notes: •, not applicable; +, low risk of bias; −, high risk of bias; ?, unclear risk of bias. List of the 13 questions from the RTI Item Bank are as follows: 1. Do the inclusion/exclusion criteria vary across the comparison groups of the study? 2. Does the strategy for recruiting participants into the study differ across groups? 3. Is the selection of the comparison group inappropriate? 4. Does the study fail to account for important variations in the execution of the study from the proposed protocol? 5. Was the assessor not blinded to the outcome, exposure, or intervention status of the participants? 6. Were valid and reliable measures not used or not implemented consistently across all study participants to assess inclusion/exclusion criteria, intervention/exposure outcomes, participant benefits and harms, and potential confounders? 7. Was the length of follow-up different across study groups? 8. In cases of missing data (eg, overall or differential loss to follow-up for cohort studies or missing exposure data for case–control studies), was the impact not assessed (eg, through sensitivity analysis or other adjustment method)? 9. Are any important primary outcomes missing from the results? 10. Are any important harms or adverse events that may be a consequence of the intervention/exposure missing from the results? 11. Did the study fail to balance the allocation between the groups or match groups (eg, through stratification, matching, propensity scores)? 12. Were important confounding variables not taken into account in the design and/or analysis (eg, through matching, stratification, interaction terms, multivariate analysis, or other statistical adjustment such as instrumental variables)? 13. Are results believable taking study limitations into consideration?
Occupational exposure and COPD from JEM-based studies
| Subgroup types | Physician-diagnosed COPD
| Based on spirometry
| Physician- or spirometry-based COPD
| ||||||
|---|---|---|---|---|---|---|---|---|---|
| N | Heterogeneity ( | OR | N | Heterogeneity ( | OR | N | Heterogeneity (I | OR | |
| All (JEM studies) | 101,118 | 46.2; <0.001 | 1.36 (1.26–1.47) | 160 | 39.6; <0.001 | 1.16 (1.12–1.20) | 278 | 46.8; <0.001 | 1.22 (1.18–1.27) |
| Gender | |||||||||
| Males only | 49 | 43.2; 0.001 | 1.37 (1.22–1.55) | 21 | 0.0; 0.935 | 1.30 (1.11–1.53) | 70 | 28.3; 0.017 | 1.32 (1.21–1.45) |
| Females only | 19 | 0.0; 0.606 | 2.56 (1.95–3.36) | 18 | 0.0; 0.503 | 1.17 (0.94–1.45) | 37 | 30.0; 0.046 | 1.78 (1.42–2.23) |
| Males and females | 50 | 45.9; <0.001 | 1.23 (1.10–1.36) | 121 | 48.0; <0.001 | 1.15 (1.11–1.20) | 171 | 49.3; <0.001 | 1.18 (1.14–1.23) |
| Study design | |||||||||
| Cross-sectional | 80 | 35.3; 0.001 | 1.30 (1.18–1.44) | 87 | 31.9; 0.003 | 1.13 (1.04–1.23) | 167 | 35.1; <0.001 | 1.21 (1.13–1.29) |
| Case-control | 14 | 29.8; 0.139 | 2.35 (1.63–3.38) | 34 | 41.2; 0.0017 | 1.61 (1.40–1.84) | 58 | 54.4; <0.001 | 1.75 (1.51–2.01) |
| Cohort (longitudinal) | 24 | 66.6; <0.001 | 1.24 (1.14–1.34) | 39 | 0.0; 0.622 | 1.08 (1.06–1.10) | 53 | 26.8; 0.041 | 1.11 (1.08–1.14) |
| JEM types | |||||||||
| General population | 108 | 45.6; <0.001 | 1.41 (1.28–1.56) | 132 | 39.1; <0.001 | 1.19 (1.12–1.25) | 240 | 45.7; <0.001 | 1.26 (1.20–1.33) |
| Workplace based | 10 | 33.4; 0.141 | 1.20 (1.11–1.45) | 28 | 37.2; 0.026 | 1.10 (1.06–1.15) | 38 | 47.3; 0.001 | 1.14 (1.10–1.19) |
| Exposure period | |||||||||
| Current/longest-held job | 73 | 46.4; <0.001 | 1.50 (1.34–1.68) | 101 | 35.8; <0.001 | 1.18 (1.13–1.24) | 174 | 47.3; <0.001 | 1.28 (1.22–1.35) |
| Cumulative exposure | 35 | 33.5; 0.030 | 1.16 (0.96–1.41) | 29 | 60.3; <0.001 | 1.22 (1.01–1.48) | 64 | 48.2; <0.001 | 1.19 (1.05–1.36) |
| Exposure to VGDF | |||||||||
| Self-reported | 26 | 2.7; 0.424 | 2.33 (2.12–2.56) | 18 | 0.0; 0.501 | 1.47 (1.30–1.66) | 44 | 44.8; 0.001 | 1.91 (1.72–2.13) |
| JEM based | 23 | 44.5; 0.012 | 1.19 (1.10–1.30) | 17 | 66.8; <0.001 | 1.07 (0.92–1.25) | 40 | 58.8; <0.001 | 1.10 (1.06–1.24) |
| Level of exposure to VGDF | |||||||||
| Low | 1 | – | 0.99 (0.63–1.56) | 3 | 91.7; <0.001 | 0.72 (0.17–3.08) | 4 | 89.4; <0.001 | 0.77 (0.29–2.05) |
| Medium | 4 | 72.4; 0.012 | 1.07 (0.75–1.54) | – | – | – | 4 | 72.4; 0.012 | 1.07 (0.75–1.54) |
| High | 5 | 44.4; 0.126 | 1.37 (1.00–1.86) | 5 | 20.6; 0.283 | 1.34 (1.07–1.68) | 10 | 26.9; 0.196 | 1.36 (1.14–1.63) |
| Exposure to the six individual pollutants forms (includes author assigned) | |||||||||
| Vapors | 14 | 53.5; 0.009 | 1.24 (0.88–1.77) | 24 | 16.1; 0.239 | 1.26 (1.10–1.44) | 38 | 33.3; 0.026 | 1.24 (1.08–1.42) |
| Gases | 26 | 0.0; 0.610 | 1.09 (0.97–1.21) | 23 | 10.4; 0.319 | 1.12 (1.01–1.25) | 49 | 0.0; 0.509 | 1.10 (1.04–1.17) |
| Dusts | 62 | 49.1; <0.001 | 1.44 (1.24–1.66) | 97 | 23.8; 0.024 | 1.12 (1.08–1.16) | 155 | 39.3; <0.001 | 1.37 (1.30–1.45) |
| Biological dusts | 26 | 67.1; <0.001 | 1.90 (1.39–2.59) | 33 | 10.6; 0.294 | 1.16 (1.06–1.28) | 59 | 49.6; <0.001 | 1.33 (1.17–1.51) |
| Mineral dust | 25 | 0.0; 0.664 | 1.20 (1.09–1.31) | 37 | 0.0; 0.936 | 1.07 (1.04–1.09) | 62 | 0.0; 0.837 | 1.07 (1.05–1.09) |
| Fumes | 33 | 14.6; 0.232 | 1.17 (1.03–1.34) | 34 | 9.0; 0.320 | 1.14 (1.09–1.21) | 67 | 11.6; 0.218 | 1.16 (1.09–1.23) |
| Fibers | 3 | 71.0; 0.032 | 2.99 (0.66–13.59) | 2 | 0.0; 0.432 | 1.34 (0.72–2.47) | 5 | 48.8; 0.099 | 1.76 (0.89–3.47) |
Notes: N is the number of individual point risk estimates from the studies;
compared to nonexposed individuals;
exposures to specific substances from JEM studies were assigned by authors SS and OPK to one of the six pollutant forms, that is, vapors, gases, dusts, fumes, fibers, and mists, and VGDF. For example, the reported JEM risk estimates for silica were assigned to dust.
Abbreviations: JEM, job exposure matrices; OR, odds ratio; CIs, confidence intervals; VGDF, vapors, gases, dust, or fumes.
Occupational exposure and respiratory symptoms and chronic bronchitis from JEM-based studies
| Subgroup types | Breathlessness
| Chronic bronchitis
| ||||
|---|---|---|---|---|---|---|
| N | Heterogeneity ( | OR (95% CI) | N | Heterogeneity ( | OR (95% CI) | |
| All (JEM studies) | 56 | 0.0; 0.518 | 1.24 (1.17–1.31) | 228 | 53.7; <0.001 | 1.33 (1.26–1.40) |
| Gender | ||||||
| Males only | 30 | 24.4; 0.115 | 1.25 (1.14–1.38) | 81 | 73.5; <0.001 | 1.31 (1.20–1.42) |
| Females only | 17 | 0.0; 0.962 | 1.32 (1.19–1.48) | 53 | 28.5; 0.030 | 1.22 (1.08–1.38) |
| Males and females | 9 | 0.0; 0.754 | 1.13 (0.98–1.31) | 94 | 12.5; 0.163 | 1.37 (1.29–1.45) |
| Study design | ||||||
| Cross-sectional | 24 | 20.8; 0.179 | 1.23 (1.14–1.34) | 194 | 56.5; <0.001 | 1.36 (1.28–1.44) |
| Case–control | – | – | – | – | – | – |
| Cohort (longitudinal) | 32 | 0.0; 0.797 | 1.28 (1.15–1.41) | 34 | 25.4; 0.091 | 1.20 (1.08–1.34) |
| JEM type | ||||||
| Expert community JEMs | 56 | 0.0; 0.518 | 1.24 (1.17–1.31) | 213 | 31.0; <0.001 | 1.29 (1.23–1.35) |
| Workplace-based JEMs | – | – | – | 15 | 92.1; <0.001 | 1.73 (1.37–2.19) |
| Exposure period | ||||||
| Current/longest-held job | 45 | 0.0; 0.497 | 1.31 (1.22–1.41) | 176 | 57.2; <0.001 | 1.33 (1.25–1.41) |
| Cumulative exposure | 11 | 0.0; 0.918 | 1.15 (1.06–1.24) | 36 | 29.6; <0.001 | 1.27 (1.14–1.42) |
| Exposure to VGDF | ||||||
| Self-reported | 2 | 41.4; 0.191 | 1.35 (1.14–1.60) | 28 | 45.7; 0.005 | 1.60 (1.47–1.74) |
| JEM based | 12 | 0.0; 0.572 | 1.22 (1.11–1.35) | 35 | 23.5; 0.108 | 1.24 (1.14–1.34) |
| Levels of exposure to VGDF | ||||||
| Low | 4 | 0.0; 0.556 | 1.12 (0.88–1.43) | 11 | 0.0; 0.747 | 1.02 (0.90–1.16) |
| High | 6 | 0.0; 0.520 | 1.56 (1.16–2.09) | 12 | 0.0; 0.734 | 1.48 (1.28–1.70) |
| Exposure to the six individual pollutants forms (includes author assigned) | ||||||
| Vapors | – | – | – | 37 | 19.7; 0.148 | 1.40 (1.21–1.62) |
| Gases | 14 | 21.3; 0.222 | 1.21 (1.04–1.41) | 42 | 33.6; 0.020 | 1.21 (1.09–1.35) |
| Dusts | 28 | 0.0; 0.526 | 1.25 (1.14–1.37) | 117 | 32.5; 0.001 | 1.42 (1.32–1.52) |
| Biological dusts | 14 | 25.6; 0.178 | 1.28 (1.08–1.52) | 46 | 25.8; 0.059 | 1.33 (1.19–1.49) |
| Mineral dusts | 14 | 0.0; 0.826 | 1.23 (1.08–1.40) | 53 | 35.5; 0.006 | 1.38 (1.25–1.52) |
| Fumes | 14 | 21.3; 0.222 | 1.21 (1.04–1.41) | 52 | 36.4; <0.001 | 1.29 (1.16–1.42) |
| Fibers | – | – | – | 8 | 95.2; <0.001 | 1.60 (1.15–2.22) |
Notes: N is the number of individual point risk estimates from the studies;
exposures to specific substances from JEM studies were assigned by authors SSS and OPK to one of the six pollutant forms, that is, vapors, gases, dusts, fumes, fibers, and mists, and VGDF. For example, the reported JEM risk estimates for silica were assigned to dust.
Abbreviations: JEM, job exposure matrices; OR, odds ratio; CIs, confidence intervals; VGDF, vapors, gases, dust, or fumes.
Figure 2Funnel plot of studies reporting COPD (diagnosed by spirometry) associated with exposure to occupational airborne pollutants.
Figure 3Funnel plot of studies reporting COPD (diagnosed by spirometry or physician) associated with exposure to occupational airborne pollutants.